GHRP-6 Acetate 10mg
A research-use ghrelin-receptor peptide entry for endocrine-axis context and safety review.
Contents
Use this guide as a structured review page. The same headings appear for every protocol so clients and the care team can scan the page consistently.
Quickstart Highlights
GHRP-6 (Growth Hormone-Releasing Peptide 6) is a synthetic hexapeptide that functions as a potent growth hormone secretagogue by binding to the ghrelin receptor (GHS-R1a)[1][2]. It stimulates pulsatile GH release from the pituitary gland while maintaining physiological feedback controls, resulting in elevated IGF-1 levels and potential anabolic benefits[3]. This educational protocol presents a three-times-daily subcutaneous approach using practical dilution for precise insulin-syringe measurements.
- Reconstitute: Add 3.0 mL bacteriostatic water → ~3.33 mg/mL concentration.
- Typical daily range: 300–900 mcg total (split into 3 doses with gradual titration).
- Easy measuring: At 3.33 mg/mL, 1 unit = 0.01 mL ≈ 33.3 mcg on a U-100 insulin syringe.
- Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and use within 7 days.
Dosing & Reconstitution Guide
Educational guide for reconstitution and daily dosing
| Week/Phase | Dose per Injection (mcg) | Units (per injection) (mL) |
|---|---|---|
| Weeks 1–2 | 100 mcg | 3 units (0.03 mL) |
| Weeks 3–4 | 200 mcg | 6 units (0.06 mL) |
| Weeks 5–12 | 300 mcg | 9 units (0.09 mL) |
- Frequency: Inject three times daily subcutaneously, spaced at least 4 hours apart (morning, midday, bedtime). GHRP-6 has a short half-life of approximately 2.5 hours[4], making multiple daily injections more effective than once-daily dosing for sustained GH elevation[5]. Each injection should be administered on an empty stomach (2–3 hours after meals, 30 minutes before eating) to maximize GH release[6].
- For ≤10-unit (≤0.10 mL) administrations, consider 30- or 50-unit insulin syringes for improved readability.
Reconstitution Steps
Reference-derived details for GHRP-6 Acetate 10mg.
- Draw 3.0 mL bacteriostatic water with a sterile syringe.
- Inject slowly down the vial wall to avoid foaming; do not shake.
- Gently swirl or roll the vial until the powder is completely dissolved.
- Label with date and concentration, then refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
- Use within 7 days of reconstitution for optimal potency.
Supplies Needed
Plan based on a 12-week protocol with three-times-daily injections and gradual titration.
- Peptide Vials (GHRP-6, 10 mg each):
- Peptide Vials (GHRP-6, 10 mg each):: 12 weeks ≈ 7 vials (based on gradual titration to 300 mcg × 3 daily)
- Insulin Syringes (U-100):
- Insulin Syringes (U-100):: Per week: 21 syringes (3/day × 7 days)
- Insulin Syringes (U-100):: 12 weeks: 252 syringes (recommend 3 × 100-count boxes)
- Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.
- Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.: 12 weeks (7 vials): 21 mL → 3 × 10 mL bottles
- Alcohol Swabs: One for the vial stopper + one for the injection site per injection.
- Alcohol Swabs: One for the vial stopper + one for the injection site per injection.: Per week: 42 swabs (2 per injection × 3 daily × 7 days)
- Alcohol Swabs: One for the vial stopper + one for the injection site per injection.: 12 weeks: 504 swabs → recommend 6 × 100-count boxes
Protocol Overview
Concise summary of the three-times-daily regimen.
- Goal: Stimulate pulsatile GH release to support muscle growth, fat loss, and recovery[2][7]. Open source
- Schedule: Three subcutaneous injections daily for 8–12 weeks, spaced at least 4 hours apart.
- Dose Range: 100–300 mcg per injection with gradual titration (300–900 mcg total daily).
- Reconstitution: 3.0 mL per 10 mg vial (~3.33 mg/mL) for accurate unit measurements.
- Storage: Lyophilized frozen; reconstituted refrigerated; use within 7 days.
Dosing Protocol
Suggested titration approach with multiple daily doses.
- Start: 100 mcg per injection, 3× daily (300 mcg total) for Weeks 1–2.
- Increase: 200 mcg per injection, 3× daily (600 mcg total) for Weeks 3–4.
- Target: 300 mcg per injection, 3× daily (900 mcg total) for Weeks 5–12.
- Timing: On empty stomach; space injections at least 4 hours apart; wait 30 minutes before eating.
- Cycle Length: 8–12 weeks; rotate injection sites to prevent tissue irritation.
Storage Instructions
Proper storage preserves peptide quality and potency.
- Use new sterile insulin syringes for each injection; dispose in a sharps container[9]. Open source
- Rotate injection sites systematically (abdomen, thighs, upper arms) to reduce lipohypertrophy and local irritation[10]. Open source
- Inject slowly and wait a few seconds before withdrawing the needle.
- GHRP-6 may increase appetite in some users due to its ghrelin-mimicking properties[11]. Open source
- Document daily doses, timing, and sites to maintain consistency throughout the cycle.
Important Notes
Practical considerations for consistency and safety.
- Use new sterile insulin syringes for each injection; dispose in a sharps container[9]. Open source
- Rotate injection sites systematically (abdomen, thighs, upper arms) to reduce lipohypertrophy and local irritation[10]. Open source
- Inject slowly and wait a few seconds before withdrawing the needle.
- GHRP-6 may increase appetite in some users due to its ghrelin-mimicking properties[11]. Open source
- Document daily doses, timing, and sites to maintain consistency throughout the cycle.
How This Works
GHRP-6 functions as a synthetic ghrelin mimetic by binding to the growth hormone secretagogue receptor (GHS-R1a) in the pituitary gland and hypothalamus[1][12]. This activation triggers acute, pulsatile growth hormone release from somatotroph cells while simultaneously reducing somatostatin’s inhibitory brake on GH secretion[3]. Unlike continuous GH administration, GHRP-6 maintains physiological feedback controls—as GH and IGF-1 levels rise, endogenous somatostatin increases to prevent excessive elevation, keeping GH pulses within normal physiologic ranges[5].
- Beyond its endocrine effects, GHRP-6 exhibits cytoprotective properties through interactions with the CD36 receptor on immune and muscle cells[2][13]. This secondary pathway activates cell-survival signaling cascades (such as PI3K/Akt) that help protect tissues from oxidative stress and inflammation, explaining many of GHRP-6’s observed tissue-protective benefits in preclinical models including cardioprotection, neuroprotection, and anti-fibrotic effects[2][14].
Potential Benefits & Side Effects
Observations from clinical and preclinical literature.
- Muscle Growth & Fat Loss: Elevated GH and IGF-1 levels support increased lean body mass and reduced fat mass over time[7][15]. Open source
- Enhanced Recovery: Improved sleep architecture (increased slow-wave sleep) and faster tissue repair[16]. Open source
- Appetite Stimulation: May increase hunger due to ghrelin receptor activation, potentially beneficial for weight gain goals[11]. Open source
- Tissue Protection: Preclinical studies show cytoprotective effects including reduced scar formation, cardioprotection, and neuroprotection[2][14][17]. Open source
- Joint & Connective Tissue Health: May support collagen synthesis and connective tissue repair through elevated IGF-1[7]. Open source
- Transient mild increases in cortisol and ACTH (typically not clinically significant)[18]. Open source
- Increased appetite and potential water retention.
- Occasional injection-site reactions (redness, itching, mild swelling).
- Possible transient dizziness or flushed feeling immediately after injection due to rapid GH spike.
- Generally well-tolerated in human trials at research doses with no major safety concerns reported[19]. Open source
Lifestyle Factors
Complementary strategies for optimizing outcomes.
- Nutrition: Maintain adequate protein intake (1.6–2.2 g/kg body weight) to support anabolic processes. Time carbohydrate and fat intake away from injections to maximize GH release[6]. Open source
- Training: Combine resistance training with moderate cardiovascular activity to leverage elevated GH/IGF-1 for muscle growth and fat oxidation.
- Sleep: Prioritize 7–9 hours of quality sleep; GHRP-6’s effects on sleep architecture may enhance recovery[16]. Open source
- Hydration: Maintain proper hydration to support metabolic processes and minimize water retention.
- Stress Management: Chronic stress can interfere with GH secretion; incorporate stress-reduction techniques.
Injection Technique
General subcutaneous guidance from clinical best-practice resources[20][21].
- Preparation: Clean the vial stopper and injection site with alcohol swabs; allow to dry completely.
- Drawing the dose: Use a new sterile insulin syringe; draw the calculated units and check for air bubbles.
- Site selection: Rotate between abdomen (2+ inches from navel), outer thighs, and upper arms. Avoid repeatedly injecting the same spot[10][22]. Open source
- Technique: Pinch a skinfold; insert needle at 45–90° angle into subcutaneous tissue (angle depends on needle length and body fat)[20][21]. Open source
- Administration: Do not aspirate for subcutaneous injections. Inject slowly and steadily; hold for a few seconds before withdrawing[20]. Open source
- Disposal: Immediately dispose of used syringes and needles in a puncture-proof sharps container. Never reuse needles[9]. Open source
Recommended Source
We recommend Prime Lab Peptides for high-purity GHRP-6 (10 mg).
- High-purity, third-party-tested peptides with batch Certificates of Analysis (COAs).
- Consistent quality control and ISO-aligned handling procedures.
- Reliable fulfillment with proper cold-chain maintenance.
- Transparent documentation and responsive customer support.
Important Note
This page is informational and does not authorize use. Peptify clients should complete assessment, disclose medications and health history, and follow the clinician-approved plan only.
- Do not start, stop, combine, or change a protocol based only on website content.
- Emergency symptoms require urgent medical care, not a website or routine follow-up message.
References
Reference-derived details for GHRP-6 Acetate 10mg.
- GHRP-6 (10mg Vial) Open source
- European Journal of Endocrinology (1997) — Growth hormone-releasing peptides: comprehensive review of GHRP mechanisms and effects View Source Open source
- Clinical Medicine Insights: Cardiology (2017) — Synthetic GHRPs: historical appraisal of cytoprotective effects and mechanisms View Source Open source
- Wikipedia — GHRP-6: structure, pharmacology, and mechanism of action overview View Source Open source
- European Journal of Pharmaceutical Sciences (2013) — Pharmacokinetic study of GHRP-6 in healthy male volunteers View Source Open source
- European Journal of Endocrinology (1997) — Pulsatile GH secretion and feedback mechanisms with GHRPs View Source Open source
- Clinical Medicine Insights: Cardiology (2017) — Effect of nutrient intake on GHRP-induced GH release View Source Open source
- Sexual Medicine Reviews (2018) — Safety and efficacy of growth hormone secretagogues View Source Open source
- Assay Genie Product Datasheet (2021) — GHRP-6 recombinant protein: storage and handling recommendations View Source Open source
- CDC (2024) — Preventing unsafe injection practices: basic injection safety guidelines View Source Open source
- CDC (2024) — 4 ways to take insulin: injection sites and rotation strategies View Source Open source
- Clinical Medicine Insights: Cardiology (2017) — Ghrelin receptor activation and orexigenic effects of GHRP-6 View Source Open source
- Wikipedia — GHRP-6 mechanism: ghrelin receptor binding and GH secretagogue activity View Source Open source
- Clinical Medicine Insights: Cardiology (2017) — CD36 receptor activation and cell-survival signaling pathways View Source Open source
- International Wound Journal (2018) — GHRP-6 prevents cutaneous hypertrophic scarring: proteome study View Source Open source
- Sexual Medicine Reviews (2018) — GH secretagogues: effects on lean body mass and fat reduction View Source Open source
- Clinical Medicine Insights: Cardiology (2017) — GHRP effects on sleep architecture and slow-wave sleep View Source Open source
- Clinical Medicine Insights: Cardiology (2017) — Cardioprotective and neuroprotective effects of GHRPs in preclinical models View Source Open source
- Clinical Medicine Insights: Cardiology (2017) — Transient ACTH and cortisol elevation with GHRP-6 administration View Source Open source
- Sexual Medicine Reviews (2018) — Safety profile of growth hormone secretagogues in human trials View Source Open source
- CDC (2024) — Vaccine administration: subcutaneous injection technique (fact sheet) View Source Open source
- CDC (2024) — Vaccine administration: during vaccination best practices View Source Open source
- Clinical Diabetes (2019) — The injection technique factor: what you don’t know or teach can make a difference View Source Open source
- Prime Lab Peptides — GHRP-6 (10 mg) product page: quality assurance and batch documentation View Source